US surgeon who campaigned against potentially dangerous device receives legal threatBMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g5577 (Published 17 September 2014) Cite this as: BMJ 2014;349:g5577
- Owen Dyer
A former Harvard surgeon who led a successful campaign against power morcellators—surgical devices designed to chop up uterine fibroids for removal through laparoscopic incisions—has said that he will continue to fight against the procedure despite having received a threatening legal letter from the manufacturer of the device, which was used on his wife.
Hooman Noorchashm, a cardiothoracic surgeon, learned in October 2013 that a routine operation to remove fibroids from his wife, Amy Reed, had spread undetected leiomyosarcoma around her peritoneal cavity, turning a stage I cancer into a stage IV.
After what he called “serious infighting” at Harvard Medical School’s Brigham and Women’s Hospital in Boston, Massachusetts, where he worked at the time and where the operation was performed, the hospital banned the procedure, which is performed …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial